Soligenix announces $1.5 million nih small business innovation research award advancing covid-19 vaccine development

Princeton, n.j., dec. 28, 2020 /prnewswire/ -- soligenix, inc. (nasdaq: sngx) (soligenix or the company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the...
SNGX Ratings Summary
SNGX Quant Ranking